Scientists supercharge Patient's own cells to hunt lymphoma
NCT ID NCT01192464
Summary
This early-phase study tests a new cell therapy for patients whose Hodgkin's or Non-Hodgkin's lymphoma has returned. Doctors take a patient's own immune cells, genetically modify them in a lab to better recognize and attack cancer cells, and then infuse them back. The main goal is to check the safety of different doses and see how long these modified cells survive in the body.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-HODGKIN'S LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Houston Methodist Hospital
Houston, Texas, 77030, United States
-
Texas Children's Hospital
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.